Being younger, having more symptom-free periods, and a delayed positive antibody test were identified as risk factors for a delayed diagnosis of myasthenia gravis (MG) in a study conducted in Denmark. While the study’s findings noted a trend toward shorter diagnosis times in more recent years, the researchers noted…
People with myasthenia gravis (MG) are just as likely to have upper respiratory tract infections (URTIs) as people in the general population, a study in Saudi Arabia suggests. Certain treatments used to manage MG, such as rituximab, an antibody-based therapy sometimes used off-label for that purpose, might increase…
The prefilled syringe used to administer Zilbrysq (zilucoplan) under the skin, or subcutaneously, can be safely and effectively used by generalized myasthenia gravis (gMG) patients, caregivers, and healthcare providers, a usability study in the U.S. shows. Most participants were able to use the syringe, which contained a placebo…
Mycophenolate mofetil (MMF) safely and effectively controlled symptoms of generalized myasthenia gravis (gMG) in patients switching from azathioprine, another immunosuppressive agent, a study finds. “This study supports the efficacy and safety of MMF in the treatment of MG,” wrote the study’s researchers, who said more research with a…
Taking Rituximab by itself is as effective as combining it with corticosteroids for treating myasthenia gravis (MG) and has the benefit of reducing the proportion of patients who need rescue therapy and use immunosuppressants, a French study finds. According to researchers, “this indicates that avoiding steroids could reduce…
More than half of myasthenia gravis (MG) patients have fatigue, the severity of which is strongly correlated with their history of exacerbations, that is episodes when their disease worsens, and/or crises, along with delays in their diagnosis. That’s according to a nationwide registry study in Germany that found…
A set of inflammatory molecules could be useful as biomarkers for identifying and classifying myasthenia gravis (MG), potentially aiding in the diagnosis of the rare neuromuscular disease, according to a new study led by researchers in Sweden. Proteins and regulatory molecules associated with inflammatory processes could serve as disease…
A recent study has reported a potential connection between cancer development and a subtype of myasthenia gravis (MG). The study, conducted in Italy, revealed the presence of muscle-specific kinase (MuSK) protein in tumor samples from patients with MuSK myasthenia gravis (MuSK-MG). The data also indicated a higher likelihood…
Get regular updates to your inbox.
